Thomas Hank
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 53
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 9
- Surgery top 5%
- Pancreatitis Pathology and Treatment 26
- Cholangiocarcinoma and Gallbladder Cancer Studies 10
-
- Renal cell carcinoma treatment 10
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 15
-
- Radiomics and Machine Learning in Medical Imaging 4
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Oliver StrobelMarkus W. BüchlerThilo HackertUlf HinzFrank BergmannDirk JägerChristoph SpringfeldPeter Schirmacher
- Cited by
- OncologyCancer ResearchSurgery
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Thomas Hank
51 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 61
- Oncology 1.2k
- Cancer Research 331
- Surgery 621
- Pulmonary and Respiratory Medicine 454
- Epidemiology 359
Countries citing papers authored by Thomas Hank
This map shows the geographic impact of Thomas Hank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hank more than expected).
Fields of papers citing papers by Thomas Hank
This network shows the impact of papers produced by Thomas Hank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hank. The network helps show where Thomas Hank may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Hank, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 21 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 20 | |
| 17 | 2021 | 41 | |
| 18 | 2021 | 3 | |
| 19 | 2017 | 45 | |
| 20 | 2014 | 180 |
About Thomas Hank
Thomas Hank is a scholar working on Oncology, Surgery and Cancer Research, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (53 papers), Pancreatitis Pathology and Treatment (26 papers), Neuroendocrine Tumor Research Advances (15 papers), Renal cell carcinoma treatment (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Cancer Genomics and Diagnostics (9 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (331 citations) and Surgery (621 citations). Thomas Hank has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Oliver Strobel, Markus W. Büchler, Thilo Hackert, Ulf Hinz, Frank Bergmann, Dirk Jäger, Christoph Springfeld, Peter Schirmacher, Jens Werner and Willem Niesen. Their work appears in journals such as Annals of Surgery, Pancreatology, HPB, European Journal of Surgical Oncology and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.